https://www.indianpharmapost.com/abbott-announces-worlds-first-implant-of-dual-chamber-leadless-pacemaker-in-pivotal-trial-112162022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/origin-materials-and-minafin-form-strategic-partnership-for-biobased-chemicals-112282022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-approval-from-usfda-for-arformoterol-tartrate-inhalation-112272022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/suven-pharma-q3fy22-pat-at-rs-16006-crore-112262022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/asterdm-healthcare-q3fy22-pat-at-rs-14834-cr-112252022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-india-q3fy22-pat-at-rs-10088-cr-112242022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-kgaa-restructures-life-science-business-to-support-long-term-growth-112232022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/glaxosmithkline-pharmaceuticals-delivers-strong-financials-in-q3fy22-112222022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/wockhardt-gets-cdsco-nod-to-export-100-million-doses-of-sputnik-vaccines-112212022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/biogen-and-xbrane-announce-commercialization-and-license-agreement-for-biosimilar-to-treat-rheumatoid-arthritis-112202022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/everest-medicines-trodelvy-approved-in-singapore-for-second-line-metastatic-triple-negative-breast-cancer-112192022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/thermo-fisher-scientific-launches-rapid-environmental-pcr-testing-solution-112182022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/azurity-pharma-gets-usfda-approval-for-fleqsuvy-112172022-02-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/biosynthetic-technologies-raises-75-million-112292022-02-08T00:00:00+05:30always0.9